Has Satyaki Banerjee received payments from drug or device companies?

Yes. Drug and device makers reported $259,889 in general payments to Satyaki Banerjee across 703 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Satyaki Banerjee did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Satyaki Banerjee come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Satyaki Banerjee

Nephrology · Albuquerque, NMNPI 1790815926

Payments from drug & device makers

$259,889in general payments, 2019–2025

Across 703 payments — averaging $369.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$170K
Angiodynamics, Inc.$24K
W. L. Gore & Associates, Inc.$22K
Mozarc Medical US LLC$19K
Covidien LP$11K
Cordis US CORP.$6K
plus $8K from 42 others

What the payments were for

Consulting fees$44,87617%
Speaking & faculty fees$137,04053%
Travel & lodging$42,40416%
Food & beverage$14,7136%
Education$1,6551%
Other$19,2007%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	162	$169,654
Angiodynamics, Inc.	10	$23,552
W. L. Gore & Associates, Inc.	48	$21,886
Mozarc Medical US LLC	103	$19,122
Covidien LP	18	$11,319
Cordis US CORP.	15	$6,015
Bard Peripheral Vascular, Inc.	138	$2,756
Boston Scientific	6	$892
AstraZeneca(2 entities)	32	$543
Nxstage Medical, Inc.	7	$525
Vifor Pharma, Inc.	30	$505
Daiichi Sankyo Inc.	41	$471
Merit Medical Systems Inc	1	$350
Otsuka America Pharmaceutical, Inc.	15	$300
Philips North America LLC	3	$233
Medline Industries LP	5	$182
Aurinia Pharma U.S., Inc.	7	$152
Mallinckrodt Hospital Products Inc.	2	$139
Baxter Healthcare	1	$120
Fresenius USA Marketing, Inc.	6	$119
Bayer	7	$117
Novartis	6	$113
Outset Medical Inc	1	$101
Amgen(2 entities)	4	$80
Calliditas Therapeutics US Inc.	4	$72
GSK	4	$53
Penumbra, Inc.	2	$50
Ultragenyx Pharmaceutical Inc.	2	$47
Cook Medical LLC	3	$46
Convatec Inc.	1	$34
Novo Nordisk	2	$33
Veloxis Pharmaceuticals, Inc.	1	$31
Travere Therapeutics, Inc.	1	$26
Shield Therapeutics Inc	1	$22
Sanofi	1	$22
Lilly USA, LLC	1	$21
Kiniksa Pharmaceuticals, Ltd.	1	$21
Tactile Systems Technology Inc	1	$19
Merck	1	$17
Amicus Therapeutics, Inc.	1	$17
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$16
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$16
Kerecis Limited	1	$15
E.r. Squibb & Sons, L.L.C.	1	$14
Siemens Medical Solutions USA, Inc.	1	$14
Chiesi USA, Inc.	1	$13
Avenu Medical Inc.	1	$11
Mallinckrodt Enterprises LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Argyle$187,768
VenaCure 1470 Pro$23,418
VIABAHN Endoprosthesis$12,780
ACUSEAL Vascular Graft$7,883
Palindrome$6,231
Varithena Administration Pack$828
VenaSeal$703
WRAPSODY Endovascular Stent Graft System$350
Chameleon$249
RADIAL 360$150
ClosureFast$136
TERLIVAZ$124
Renal - PD$120
Auryon Laser System 100-120 Vac$110
PUREFLOW SL$109
NXSTAGE SYSTEM ONE$109
LUTONIX$104
MyCareLink$101
SABER$100
ELLIPSYS VASCULAR ACCESS SYSTEM$100

How this compares

$259,889 in reported general payments places this provider in the 95th percentile of 68 nephrology providers in New Mexico.

See all nephrology providers in New Mexico →

Medicare billing

Part B allowed, 2024

$414,641

Medicare patients

193

Services billed

987

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clindamycin Hcl	11	$71
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	18	$71

Paid to pharmacies, not to this prescriber.

Other nephrology in Albuquerque

Jayant KumarAlbuquerque$2.9M
Karen ServillaAlbuquerque$324K
Eric BrownAlbuquerque$105K
Christos ArgyropoulosAlbuquerque$85K
Darren SchmidtAlbuquerque$84K
Arun RajasekaranAlbuquerque$70K
George Vasquez RiosAlbuquerque$57K
Pablo GarciaAlbuquerque$15K
Kavitha GantaAlbuquerque$12K
Luis Madera MarinAlbuquerque$7K

See the full list for New Mexico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →